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Abstract
Background: Little is known about the fertility desires of HIV infected individuals on highly active antiretroviral
therapy (HAART). In order to contribute more knowledge to this topic we conducted a study to determine if HIV-
infected persons on HAART have different fertility desires compared to persons not on HAART, and if the
knowledge about HIV transmission from mother-to-child is different in the two groups.
Methods: The study was a cross-sectional survey comparing two groups of HIV-positive participants: those who
were on HAART and those who were not. Semi-structured interviews were conducted with 199 HIV patients living
in a rural area of western Uganda. The desire for future children was measured by the question in the
questionnaire “Do you want more children in future.” The respondents’ HAART status was derived from the
interviews and verified using health records. Descriptive, bivariate and multivariate methods were used to analyze
the relationship between HAART treatment status and the desire for future children.
Results: Results from the multivariate logistic regression model indicated an adjusted odds ratio (OR) of 1.08 (95%
CI 0.40-2.90) for those on HAART wanting more children (crude OR 1.86, 95% CI 0.82-4.21). Statistically significant
predictors for desiring more children were younger age, having a higher number of living children and male sex.
Knowledge of the risks for mother-to-child-transmission of HIV was similar in both groups.
Conclusions: The conclusions from this study are that the HAART treatment status of HIV patients did not
influence the desire for children. The non-significant association between the desire for more children and the
HAART treatment status could be caused by a lack of knowledge in HIV-infected persons/couples about the
positive impact of HAART in reducing HIV transmission from mother-to-child. We recommend that the health care
system ensures proper training of staff and appropriate communication to those living with HIV as well as to the
general community.
Keywords: highly active antiretroviral therapy, fertility desires, family planning, HIV/AIDS, knowledge, mother-to-
child-transmission, peri-natal transmission, resource-limited setting, Uganda
Background
The decision whether or not to have children is often
complex and influenced by many factors. HIV-positive
individuals in Africa have additional considerations to
take into account when deciding whether or not to have
children. These include the possibility of passing HIV
from mother-to-child and the likelihood that one or
both parents could die prior to the child reaching adult-
hood [1]. Mother-to-child transmission (MTCT) of HIV
happens in either of two ways: through perinatal infec-
tion and through breastfeeding. Regardless of these con-
cerns, many Africans after receiving a positive HIV
diagnosis still elect to have children for various personal,
cultural and economic reasons [2]. In most African
societies a common expectation of marriage is that the
couple will have children [3]. This is an especially
important expectation in Uganda as children become
members of the paternal clan [4]. In African societies
women are often valued by their ability to bear children
and a very high social good is placed on fertility; there-
fore, the pressure on women to have children is very
high [5].
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parent or couple is a situation faced by many families in
sub-Saharan African countries. However, the advent of
available highly active antiretroviral therapy (HAART) in
many sub-Saharan African countries has changed the
situation for HIV-positive persons. HAART has been
shown to drastically reduce the risk of MTCT of HIV:
T h er i s ko fM T C Ti nD e n m a r kw a sl e s st h a n1 %i na l l
HIV-positive women (all on HAART) who gave birth
between 2000-2005, and 1.7% in a large reference center
for pregnant HIV-positive women in Belgium [6,7].
Similarly, HAART has been found to reduce the risk of
vertical transmission of HIV in sub-Saharan African
countries. For example, the risk of MTCT of HIV in
women from a general sample from several sub-Saharan
African countries decreased from 30.9% in untreated
women to 4.9% in women on HAART [8]. Similarly, in
Botswana, the number of new pediatric HIV infections
has dropped from 4,600 in 1999 to 890 in 2007 due to
nearly complete coverage of an effective antiretroviral
treatment program [9]. In Cote d’Ivoire, the MTCT rate
of HIV was 5.6% in formula-fed infants and 6.8% in
infants with short-term breastfeeding reported by
mothers on HAART [10]. These figures show the vast
benefits of HAART in reducing the risk of vertical
transmission of HIV. Some studies from sub-Saharan
Africa have shown that an HIV diagnosis causes people
generally to choose to have fewer children [3,11,12].
Other research has shown that HIV infection does not
have a marked impact on fertility decisions, particularly
for those who do not show signs or symptoms of disease
[2,13,14].
Based on many reports indicating that HAART provi-
sion significantly decreases the risk of vertical transmis-
sion of HIV, one could expect that HIV-positive
mothers/couples on HAART in sub-Saharan African
countries would by now be more likely to opt to have
children. It is therefore important to investigate if volun-
tary testing and counseling (VCT) for HIV infection and
programs to prevent mother-to-child transmission
(PMTCT) of HIV services are effective in counseling
their clients on these recent findings and benefits of
HAART. One study from South Africa stated that
HAART increased the fertility desire in couples over
time [15]. Similarly, a pan African study from seven
countries showed that the pregnancy rate of HIV-posi-
tive women on HAART was significantly higher com-
pared to those not on HAART [16]. A Zimbabwean
s t u d yf o u n dt h a tw o m e no nH A A R Tw e r em o r el i k e l y
to plan for a future child, but some women still had
doubts about the effectiveness of HAART to prevent
mother-to-child transmission of HIV [17].
Ugandan studies on the association between HAART
and fertility revealed mixed results. One study from
rural south-western Uganda showed that HIV-positive
women on HAART had an increased desire for children
but did not experience an increase in actual fertility
[18]. Similarly, another study from rural eastern Uganda
showed that HAART was not associated with pregnancy
[19]. A survey of women attending Mbarara hospital in
south-western Uganda revealed that HIV-positive
women had a lower desire for future children irrespec-
tive of their HAART treatment status than HIV-negative
women [20]. Another study from Mbarara district in
south-western Uganda, found that HIV-positive women
on HAART were more than three times likely to use
contraception compared to those not on HAART [21].
In contrast to these findings, one study from Rakai dis-
trict in central Uganda described a significant positive
association between HAART treatment and becoming
pregnant in 712 women attending a hospital [22].
The participants in the above mentioned studies
included mostly only HIV-positive women, that is, HIV-
positive men were not interviewed. Male involvement in
reproductive health and fertility has long been recog-
nized as important, but has not been achieved in a tan-
gible way in many sub-Saharan African countries
[23-25]. In order to have a balanced view on whether
being on HAART changes fertility desires of individuals
and couples, it is crucial to include both sexes. We
interviewed male and female HIV-positive participants
on this issue. The objectives of the study were:
1. To investigate whether HIV-positive persons on
HAART had different fertility desires compared to HIV-
positive persons not on HAART and whether these
were different between men and women;
2. To assess the knowledge of mother-to-child trans-
mission of HIV in participants on HAART and not on
HAART.
The study took place from September to December
2006 in two districts, Kabarole and Kamwenge, in wes-
tern Uganda. Other results from the main quantitative
component of this study on fertility and HIV status are
published elsewhere [26].
Methods
Study setting
Participants were recruited through correct health cen-
tres located in Rwimi and Kibiito sub-counties in Kabar-
ole District, and the Bigodi sub-county in Kamwenge
District. The government-run health centers were
located along two major roads and offered clinical and
public health services, as well as VCT programs to pre-
vent mother-to-child transmission of HIV. The Rwimi
and Kibiito Health Centres also offered free HAART for
eligible HIV patients (CD4 cell count < 200 cells/ml
and/or WHO stage 3 and higher). The area surrounding
these health centres has a predominantly agricultural-
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occupation. This area is very fertile, allowing for high
yields of basic food crops such as maize, cassava, cook-
ing banana and beans.
Study design
The study applied a cross-sectional, quantitative design.
We report the findings based on a survey which used a
structured questionnaire administered through inter-
views to gather data from participants.
Recruitment of participants
The study inclusion criteria were: age 18-44 years, mar-
ried or cohabitating with a partner and having a positive
HIV test result. Persons who were bedridden were
excluded from the study. All HIV-positive persons regis-
tered at two health centers (Rwimi and Kibiito) were
invited to participate in the study. In order to increase
the sample size, all HIV-positive individuals of an HIV
patient support group in Bigodi sub-county were also
included in the study. Individuals identified were con-
tacted by health care workers and asked to participate
in the study. Ninety-two percent of eligible patients
agreed to be interviewed. Participants had the option of
being interviewed either in their home or at their local
health centre. Of the 199 persons who participated in
the study, 122 individuals were on HAART and 77 were
not on HAART. The HAART status was derived from
interviews and verified using health records.
Data collection and analysis
A questionnaire was developed in consultation with
local experts to assess the socio-demographic character-
istics of the study participants. Most questions used
w e r ed e r i v e df r o mp u b l i s h e ds o u r c e sa n dw e r ea l r e a d y
tested for its reliability and validity, e.g. questions
derived from the Ugandan Demographic and Health
Survey [27]. The questionnaire included questions
related to HIV testing, HIV status and fertility desires,
treatment status (HAART or no HAART), attitudes
towards childbearing of HIV-infected women/couples
and risk perceptions of MTCT of HIV. The question-
naire was translated into the local language, Rutooro,
and back translated into English for linguistic reliability.
It was pre-tested in the study area by 15 persons not
part of the study. The instruments’ reliability was
assessed through a test-retest exercise of 26 randomly
selected participants seven days after the questionnaire
was first administered. The overall percent agreement
obtained in the re-test was 92.4%. For the most impor-
tant question referring to the main study outcome vari-
able “Do you want more children in future” agreement
was 96.2%. (For those participants who reported to be
pregnant at the time of the interview this question was
phrased as “Do you want more children in future in
addition to the current pregnancy”). The final question-
naire was administered by trained interviewers in the
local language. The interviews lasted around 40 minutes.
All of the interview data was entered into Microsoft
Access and then transferred into STATA for statistical
analysis [28]. A p value of < 0.05 was considered statisti-
cally significant (all statistical tests were two sided). Data
from open-ended survey questions was coded and ana-
lyzed using descriptive statistics. The chi-square test and
t-test were used for bivariate data analysis. Bivariate and
multivariate logistic regression was used to examine and
model the variable “Desire to have more children in
future” with a binary outcome (yes/no) and HAART sta-
tus as the main covariate of interest. Independent vari-
ables included demographic and socio-economic
characteristics as well as various HIV-related factors
such as the HIV-serostatus of the respondent’s partner,
experience of any AIDS-related symptoms or illness,
and experience of an AIDS-related death (either within
their family or of a child in their community). All the
independent variables that were significant at p < 0.2 in
bivariate analyses or important confounding variables (e.
g. sex) were selected and fit into a multivariate model.
Variables found to be statistically significant in the mul-
tivariate model (p < 0.05) were kept in the final model.
Study approval and ethical considerations
Ethics approval was provided by the University of Alber-
ta’s Health Research Ethics Board Panel B. In Uganda,
approval for the study was obtained from the Uganda
National Council of Science and Technology, Kampala.
The study was also approved by the District Health Offi-
cers of Kabarole and Kamwenge districts, and the politi-
cal representatives of the study areas. Each participant
was informed about the study through an information
letter that was read to each participant. All participants
signed a consent form.
Results
Demographic and socio-economic characteristics of study
participants
One hundred twenty two (61.3%) of the study partici-
pants were female which is representative of this clinic
population. The mean age of males was 35.7 years (SD
5.7 years, range 20-44 years) while the mean age of
females was 33.3 years (SD 6.0 years, range 18-44 years).
This age difference was statistically signficant (p =
0.006). One-hundred and twenty two (61.3%) partici-
pants were currently on HAART while 77 (38.7%) were
not. More female participants were on HAART com-
pared to males (41.8% vs. 33.8%, p = 0.257). Both female
and male participants on HAART were younger com-
pared to those not on HAART (female: 31.1 vs. 34.8
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Five participants (6.5%) in the HAART group reported
to be pregnant during the survey, compared to three
( 2 . 5 % )i nt h en o n - H A A R Tg r o u p .T h em a j o r i t yo ft h e
study respondents were subsistence farmers with a pri-
mary education, living in metal-roofed mud huts. The
participants had a wide range of tribal and religious
affiliations. For more details see Table 1:
Use of effective family planning methods such as oral
contraceptives and injectables was generally low in our
respondents, however there was a high rate of condom
use. Participants on HAART reported a much lower
rate of condom use. For more details on contraceptive
use see Table 2:
Fertility desires
Overall, it was found that 13.6% of all participants
wanted to have more children. HIV- positive individuals
on HAART were more likely to want more children;
however, this difference was not statistically significant
(18.2% on HAART vs. 10.7% not on HAART, p =
0.131). Those on HAART who had two or more living
children showed a trend to want to continue childbear-
ing than those who were not on HAART (18.2% vs.
7.9%, p = 0.380). Those who wanted to continue child-
bearing wanted an average of 2.3 additional children
(2.1 for participants on HAART vs. 2.4 for participants
not on HAART). Three out of 14 pregnant women
(21.4%) and 13 out of 132 non-pregnant women (9.9%)
wanted more children (p = 0.187). For all participants,
the average number of children desired (completed
family size) was 4.3 with 3.7 children for participants on
HAART vs. 4.6 children for participants not on HAART
(p = 0.009).
In bivariate analysis, respondents who were on
HAART were slightly more likely to say that they
wanted more children in future (OR 1.86, p = 0.135),
and this trend disappeared in the multivariate model.
Results from the multivariate logistic regression analysis
indicate that the odds of desiring more children were
quite similar and not statistically different for those on
HAART compared to those not on HAART. The final
logistic regression model was adjusted for age, sex,
occupation, and number of living children. Bivariate and
multivariate logistic regression analysis results are
shown in Table 3:
A younger age, male sex, occupation as businessper-
son, and a smaller number of living children were signif-
icant predictors for the desire to have more children.
A sub-analysis was conducted to compare the fertility
desires of men and women separately as fertility inten-
tions of each sex may differ due to the diverse roles that
m e na n dw o m e np l a yi nf e r t i l i t yd e c i s i o n - m a k i n ga n d
childbearing (Table 4).
The main result of the sub-analysis was that being on
HAART was not a predictor for fertility desires of males
or females. However, the direction of the adjusted OR
was different; men on HAART had a tendency to desire
more children whereas women on HAART tended to
desire fewer children than their untreated counterparts.
Additionally, a higher number of living children was a
statistically significant predictor for a lower desire for
more children in women (OR 0.35, 95% CI 0.18-0.70).
This association was the same in men, but did not reach
statistical significance. We also found a significant asso-
ciation between the desire to have more children and
the occupational status as well as the number of living
children for females, but not for males (see Table 3).
Knowledge and risk perceptions of mother-to-child-
transmission of HIV
Participants were asked questions to assess their
k n o w l e d g eo fM T C To fH I V ,i n c l u d i n gw h e t h e ro rn o t
being on HAART would influence perceptions of
mother-to child transmission. Many respondents said
that it depended upon whether the woman delivered
her baby in the village or at the health centre/hospital.
Participants were asked if MTCT of HIV was possible
given differing treatment and delivery scenarios (see
Table 5).
The results from Table 5 show that participants gen-
erally knew being on HAART reduces the risk of
MTCT. A majority of respondents said that women on
HAART cannot transmit HIV to their unborn/newborn
child (the correct answer would have been that the
MTCT risk is minimal). Most respondents stated that
the birth setting in the hospital (as compared to a home
birth usually attended by traditional birth attendants),
was a preferred place in order to reduce MTCT as hos-
pital/health centre deliveries were perceived to be more
sanitary and were assisted by trained medical personnel.
Participants tended to think that the birth setting was
more important than the mother’s HAART status. HIV-
positive participants on HAART and those not on
HAART gave more or less the same responses. Answers
to all questions did not differ statistically based upon
the respondents’ HAART status, indicating that the
MTCT knowledge and risk perception of HIV in both
groups was the same.
The questionnaire also assessed the attitude towards
childbearing in HIV-positive women/couples. Generally,
most participants were not in favor of having children
when one or both of the parents are HIV-infected
(90.9% of participants on HAART vs. 94.4% of partici-
pants not on HAART, p = 0.496). They also thought
that their community members had a negative attitude
towards HIV-infected couples when they had a newborn
baby.
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Variable N % Want More Children p-value
a
Sex 0.131
Female 122 10.7
Male 77 18.2
Marital status 0.870
Married 109 12.8
Cohabiting 76 13.6
Occupation 0.430
Farmer/peasant 132 11.4
Businessperson 26 19.2
Other 41 17.1
Education 0.583
None 36 16.7
Lower Primary 61 11.5
Upper Primary 74 16.2
Secondary and above 28 7.1
Dwelling quality
b 0.366
Low 17 23.5
Medium 158 13.3
High 24 8.3
Ownership of Radio 0.918
No 50 14.0
Yes 149 13.4
Ownership of Bicycle 0.718
No 134 14.2
Yes 65 12.3
Ownership of Animals 0.182
No 87 17.2
Yes 112 10.7
Religious affiliation 0.911
Catholic 92 12.0
Protestant 76 15.6
Muslim 8 12.5
Other 23 13.0
Ethnic group 0.043
Mutooro 112 8.9
Mukiga 56 16.1
Other 31 25.8
ARV treatment 0.131
No 122 10.7
Yes 77 18.2
Desire for More Children
Yes (n = 27) No (n = 172)
Age in years
c, Mean ± SD 29.0 ± 5.8 35.0 ± 5.6 <0.001
d
Number of pregnancies, Mean ± SD 3.0 ± 1.8 5.2 ± 2.7 < 0.001
d
Number of living children, Mean ± SD 1.9 ± 1.3 4.3 ± 2.5 < 0.001
d
Number of non-bio children, Mean ± SD 1.0 ± 1.1 1.3 ± 1.2 0.163
d
a The p-values are based on chi-square test unless otherwise specified.
b Dwelling quality variable was divided into three categories as low, medium and high based on the house floor, wall and roof structure (low: mud floor, mud/
thatched walls and grass/thatched roof; medium: mud floor, mud/thatched walls and metal roof; high: cement/concrete/wood floor, walls of permanent materials
and metal roof or any two out of three (i.e., floor, walls and roof) of this structure).
c The percentage who wants more children for age group 18-24, 25-29, 30-34, 35-39 and 40-44 years is 42, 30, 18, 4 and 4, respectively.
d Two independent sample t-test p-value.
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This cross-sectional study conducted in western Uganda
included HIV-positive respondents on HAART and not
on HAART in order to elucidate their fertility desires as
a result of their HIV treatment status. Importantly, this
study included men and women which enabled us to
assess gender differences when the variable “fertility
desires” in conjunction with HAART was modeled for
men and women separately. Several other studies have
reviewed only fertility desires in (pregnant) women thus
missing the male partners’ perspectives on fertility
desires. These studies limited their interviews to women
perhaps because access to interviewing women is easier
and also because traditionally childbearing is generally
associated with the female gender [18,19,29,30].
Our study contributes to expanded knowledge on the
relationship between HAART treatment status and the
desire for children. We did not find that HAART treat-
ment status had an impact for the desire for children. It
is important for the scientific community and health
care workers to know this. It is also important to assess
the level of knowledge on the relationship between
MTCT and HAART in health care workers who are
working in HIV and family planning programs. They
should be aware of the impact of HAART on fertility
desires (and on possible negative maternal pregnancy
outcomes) in order to provide updated, balanced and
effective counselling for family planning and HIV care
and prevention program clients.
Our main study finding was that we did not detect an
association between being on HAART and an increased
desire for future children. Therefore, it is not likely a
consideration by HIV-infected persons and couples in
their discussions about planning and achieving their
desired family size. This corresponds to what Homsy et
al. found in their study from eastern Uganda [19] and
what Snow described from Mbarara [20].
Males were generally more likely than females to want
more children which we expected and which is in accor-
dance with the literature from sub-Saharan Africa.
Other predictors for a higher fertility desire (see Table
3) were younger age, higher number of living children,
and higher occupational status (only for women), which
are consistent with other findings from the literature for
sub-Saharan Africa. In the gender-specific sub-analysis,
men on HAART had a tendency to desire more children
compared to those men not on HAART, while women
on HAART had less desire for future children compared
to women not on HAART (both associations were not
statistically significant). However, these results from the
sub-analysis have to be considered with caution, as the
95% confidence intervals were very wide and difficult to
interpret. In addition, the sample size in this sub-analy-
sis was small and may not provide the statistical power
to detect a statistically significant difference. The gender
differences with respect to the direction of the relation-
ship between HAART treatment and fertility desires
should be tested in larger studies with sufficient power.
If confirmed, it would be important for professionals to
use different approaches in counseling male and female
persons on their fertility options when they are HIV-
positive. It would be also important to confirm if
w o m e no nH A A R Th a v el e s sd e s i r ef o rf u t u r ec h i l d r e n
than women not on HAART and, if so, why.
The non-association between fertility desires and
being on HAART treatment in HIV-infected rural
Ugandans is not too surprising, as poor rural Ugandans
with low educational attainment do not base their life
decisions on the probabilities of HIV transmission but
rather on life experiences. The hypothesis that their fer-
tility desires are based on the probability of mother-to-
child transmission of HIV seems therefore counterintui-
tive, as many other factors may play a role in fertility
desires. These factors could be whether the parents will
b ea l i v et os e et h ec h i l dg r o wa n di ft h e yw i l lb ew e l l
enough to care for the child. If parents are receiving
HAART, we can assume that they were quite sick (stage
3 or 4 or CD+ count of less than 200 cells/mm
3 [31].
This would suggest that at some point in time they have
experienced some of the more challenging aspects of liv-
ing with HIV such as morbidity and adverse reactions to
HAART treatment regimens. These experiences might
have reduced their fertility desires. In addition, the pro-
vision of HAART in Uganda is not guaranteed, making
the choice to have children especially risky for the
group relying on HAART for their well being [32]. Also,
Table 2 Contraceptive use stratified for sex and HAART treatment status of survey respondents (n = 199)
n (%) n (%)
Female (n = 122) Male (n = 77) No HAART (n = 122) HAART (n = 77)
OC Pill 4 ( 3.3) 2 ( 2.6) 3 ( 2.5) 3 ( 3.9)
Injectable 5 ( 4.1) 5 ( 6.5) 4 ( 3.3) 6 ( 7.8)
Male - Condom 67 (54.9) 47 (61.0) 87 (71.3) 27 (35.1)
Dual Method - 7 ( 9.1) 5 ( 4.1) 2 ( 2.6)
Other 10 ( 8.2) 1 ( 1.3) 5 ( 4.1) 6 ( 7.8)
Missing/No Method 36 (29.5) 15 (19.5) 18 (14.8) 33 (42.9)
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HAART is not zero and so a small risk remains.
It was surprising to find that the knowledge about
vertical transmission of HIV and its risk reduction in
mothers on HAART did not differ whether partici-
pants were on HAART or not. We expected partici-
pants in the HAART group to be more knowledgeable,
as there is the duty for the HAART clinic staff to pro-
vide the proper and updated information to their cli-
ents. This lack of knowledge is regrettable, as the
HAART clinic staff should have had many opportu-
nities as a result of their treatment program (especially
during the monthly monitoring visits) to properly
inform their clients.
Table 3 Odds ratio (OR) and 95% confidence interval (95%CI) for a dependent variable “desire to have more children”
(n = 199) - Logistic Regression Bivariate and Multivariate Analysis
Bivariate Analysis Multivariate Analysis
Variable OR (95% CI) P OR (95% CI) P
Being on HAART
No 1.00 (reference) 1.00 (reference)
Yes 1.86 (0.82-4.21) 0.135 1.08 (0.40-2.90) 0.886
Age in years 0.84 (0.77-0.91) < 0.001 0.89 (0.81-0.97) 0.012
Sex
Female 1.00 (reference) 1.00 (reference)
Male 1.86 (0.82-4.21) 0.135 3.01 (1.10-8.22) 0.032
Marital status
Married 1.00 (reference)
Cohabiting 1.07 (0.47-2.45) 0.870
Occupation
Farmer/peasant 1.00 (reference) 1.00 (reference)
Businessperson 1.85 (0.61-5.66) 0.276 3.28 (0.82-13.1) 0.092
Others 1.61 (0.61-4.26) 0.341 2.39 (0.76-7.51) 0.137
Education
None 1.00 (reference)
Lower primary 0.65 (0.20-2.11) 0.471
Upper primary 0.97 (0.12-2.83) 0.952
Secondary and above 0.38 (0.07-2.07) 0.266
Ethnic group
Mutooro 1.00 (reference)
Mukiga 1.95 (0.74-5.12) < 0.001
Other 3.55 (1.26-9.98) 0.016
Religious affiliation
Catholic 1.00 (reference)
Protestant 1.38 (0.57-3.33) 0.473
Muslim 1.05 (0.12-9.37) 0.964
Other 1.10 (0.28-4.33) 0.887
Dwelling quality
Low 1.00 (reference)
Medium 0.50 (0.15-1.67) 0.259
High 0.30 (0.05-1.84) 0.192
Pregnant
No 1.00 (reference)
Yes 2.50 (0.62-10.1) 0.200
Number of living children 0.50 (0.38-0.68) < 0.001 0.56 (0.39-0.80) 0.002
Number of non-bio children
0 1.00 (reference)
1 1.05 (0.34-3.23) 0.938
2 0.87 (0.31-2.49) 0.798
3 0.36 (0.10-1.36) 0.132
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couples receive HAART for a longer time period. We
collected our data in 2006 amidst a recent and rapid
expansion of available free HAART services in Uganda.
As we did not ask the question of the duration of
HAART treatment in our survey, we were unable to
incorporate this variable in our statistical models. It has
been suggested that the duration of HAART treatment
could play a role in the association between HAART
status and fertility desires, e.g. women on HAART treat-
m e n tf o ral o n g e rt i m em a yb em o r ei n c l i n e dt oh a v e
more children [21]. Future studies may want to include
patients with extended HAART experience to elucidate
their fertility desires.
Limitations
Our study had some limitations. First, the odds ratios
were based on cross-sectional data which precludes
assessing the causality of the associations described. Sec-
ond, social desirability bias cannot be excluded as the
information collected was sensitive. However, we used
highly trained and experienced interviewers to minimize
this bias. Third, we may have experienced a selection
bias as we were not able to perform a true random sam-
pling procedure. The fourth limitation was that we were
not able to assess any clinical parameters in regard to
the HIV disease progression of participants. As some
participants on HAART may have been in a more
advanced clinical stage of HIV, they may be less likely
wanting more children in future due to their reduced
physical health status. If this is true, we may have over-
stated the non-association between HAART and fertility
desires for more children. Finally, as free HAART was
made available in Uganda in 2005, it was likely that
some of our participants were put on HAART during
this expansion and therefore had a short duration of
antiretroviral treatment when they were interviewed by
u s .A n o t h e rs h o r t c o m i n gi st h a tt h i ss t u d yw a sc o n -
ducted in 2006; since then there have been changes in
HAART promotion and its use in Uganda, the results
should be interpreted with caution.
In addition to interviewing participants about the
desire for children, we also assessed the pregnancy sta-
tus at the time of the survey by asking the respondents
if they (or their partners) were pregnant. The proportion
for those on HAART who reported to be pregnant at
the time of the interview were similar compared to
those respondents (or their partners) not on HAART at
the time of the interviews. However, as the absolute
numbers were very small, the results from this compari-
son have limitations. In spite of these limitations, these
pregnancy numbers somewhat validate the findings
from the interviews.
Conclusions
In order to provide updated, complete, comprehensive
and balanced information during counseling and treat-
ment sessions to HIV-infected persons/couples ethically,
counseling staff has the responsibility to inform clients
not only of the benefits that can be conferred by
HAART but also of the possible risks for negative preg-
nancy outcomes [33,34]. There should be no delay in
relaying the complete educational package to this group
of HIV-positive persons and couples, as well as to the
Table 5 Knowledge and risk perception of mothers on HAART and not on HAART
% who responded that MTCT of HIV is likely under the circumstances
On HAART* Not on HAART*
If mother not on anti-retroviral treatment 92.6 96.2
If mother on anti-retroviral treatment 42.3 44.4
If mother not on anti-retroviral treatment and gives birth in village 100.0 100.0
If mother on anti-retroviral treatment and gives birth in village 76.5 67.6
If mother not on anti-retroviral treatment and gives birth in hospital 52.3 45.2
If mother on anti-retroviral treatment and gives birth in hospital 15.3 10.5
* Responses of the participants were not significantly different (i.e., p > 0.05) for those on HAART vs. not on HAART
Table 4 Odds ratio (OR) and 95% confidence interval
(95%CI) for a dependent variable “desire to have more
children” (n = 199) by sex - Logistic Regression
Multivariate Analysis
Males (n = 77) Females (n = 122)
Variable OR (95% CI) P OR (95% CI) P
Being on HAART
No 1.00
(reference)
1.00 (reference)
Yes 1.88 (0.46-7.73) 0.380 0.65 (0.13-3.32) 0.605
Age in years 0.85 (0.73-0.99) 0.031 0.91 (0.80-1.05) 0.187
Occupation
Farmer/peasant 1.00
(reference)
1.00 (reference)
Businessperson 2.49 (0.43-14.5) 0.311 11.2 (0.86-
147.1)
0.066
Others 0.55 (0.05-5.51) 0.608 10.3 (1.46-72.7) 0.019
Number of living
children
0.70 (0.43-1.14) 0.149 0.35 (0.18-0.70) 0.003
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tion services as well as family planning programs are
still not adequately addressing the benefits of HAART.
The package should be modified to include current and
updated information re: the effectiveness of HAART on
reducing vertical transmission of HIV. Health care
workers and counselors who provide HIV/family plan-
ning counseling should upgrade their MTCT/HAART
knowledge and be required to provide this information
to all service users in an unbiased way. Service providers
should be evaluated on their practice of providing this
vital, relevant and updated information to their clients.
Evidence on the positive impact of HAART on vertical
HIV transmission is crucial for the HIV-positive per-
sons/couples to know when they are making childbear-
ing decisions.
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